| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Unité Physiologie et Physiopathologie de lExercice et Handicap (A.-C.D., A.A., R.B., D.F.), EA3062, Université Jean Monnet, 42023 Saint-Etienne, France; Institute of Anatomy (A.-C.D.), University of Berne, CH-3000 Bern, Switzerland; and Département des Facteurs Humains (S.B., N.K., M.P., X.B.) and Département de Radiobiologie et Radiopathologie (C.M., A.P.), Centre de Recherche du Service de Santé des Armées, 38702 La Tronche, France
Address all correspondence and requests for reprints to: Damien Freyssenet, Unité Physiologie et Physiopathologie de lExercice et Handicap, Faculté de Médecine, 15 rue Ambroise Paré, 42023 Saint-Etienne cedex 2, France. E-mail: damien.freyssenet{at}univ-st-etienne.fr.
Myostatin is a master regulator of myogenesis and early postnatal skeletal muscle growth. However, myostatin has been also involved in several forms of muscle wasting in adulthood, suggesting a functional role for myostatin in the regulation of skeletal muscle mass in adult. In the present study, localized ectopic expression of myostatin was achieved by gene electrotransfer of a myostatin expression vector into the tibialis anterior muscle of adult Sprague Dawley male rats. The corresponding empty vector was electrotransfected in contralateral muscle. Ectopic myostatin mRNA was abundantly present in muscles electrotransfected with myostatin expression vector, whereas it was undetectable in contralateral muscles. Overexpression of myostatin elicited a significant decrease in muscle mass (10 and 20% reduction 7 and 14 d after gene electrotransfer, respectively), muscle fiber cross-sectional area (15 and 30% reduction 7 and 14 d after gene electrotransfer, respectively), and muscle protein content (20% reduction). No decrease in fiber number was observed. Overexpression of myostatin markedly decreased the expression of muscle structural genes (myosin heavy chain IIb, troponin I, and desmin) and the expression of myogenic transcription factors (MyoD and myogenin). Incidentally, mRNA level of caveolin-3 and peroxisome proliferator activated receptor
coactivator-1
was also significantly decreased 14 d after myostatin gene electrotransfer. To conclude, our study demonstrates that myostatin-induced muscle atrophy elicits the down-regulation of muscle-specific gene expression. Our observations support an important role for myostatin in muscle atrophy in physiological and physiopathological situations where myostatin expression is induced.
This article has been cited by other articles:
![]() |
H. Gilson, O. Schakman, S. Kalista, P. Lause, K. Tsuchida, and J.-P. Thissen Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E157 - E164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sartori, G. Milan, M. Patron, C. Mammucari, B. Blaauw, R. Abraham, and M. Sandri Smad2 and 3 transcription factors control muscle mass in adulthood Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1248 - C1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D. J. Glass Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1258 - C1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. LeBrasseur, T. M. Schelhorn, B. L. Bernardo, P. G. Cosgrove, P. M. Loria, and T. A. Brown Myostatin Inhibition Enhances the Effects of Exercise on Performance and Metabolic Outcomes in Aged Mice J Gerontol A Biol Sci Med Sci, May 29, 2009; (2009) glp068v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amirouche, A.-C. Durieux, S. Banzet, N. Koulmann, R. Bonnefoy, C. Mouret, X. Bigard, A. Peinnequin, and D. Freyssenet Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle Endocrinology, January 1, 2009; 150(1): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sandri Signaling in Muscle Atrophy and Hypertrophy Physiology, June 1, 2008; 23(3): 160 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Schakman, H Gilson, and J P Thissen Mechanisms of glucocorticoid-induced myopathy J. Endocrinol., April 1, 2008; 197(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Richard-Bulteau, B. Serrurier, B. Crassous, S. Banzet, A. Peinnequin, X. Bigard, and N. Koulmann Recovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activity Am J Physiol Cell Physiol, February 1, 2008; 294(2): C467 - C476. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |